|
Index of reports
> Cases resulting in life threatening events (48)
> Cases with Dyspnoea (13)
Below is the selection of adverse event reports related to Singulair (Montelukast) that includes cases resulting in life threatening events where reactions include dyspnoea.
Adverse event in 10 year old male receiving Singulair (Montelukast)
Reported by a physician from United States on 2007-10-22
Patient: 10 year old male
Adverse reactions / side effects: Death, Dyspnoea
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Singulair (Montelukast)
Other drugs received by patient: Albuterol
Adverse event in 56 year old female receiving Singulair (Montelukast)
Reported by a pharmacist from Canada on 2007-06-22
Patient: 56 year old female, weighing 84.0 kg (184.8 pounds)
Adverse reactions / side effects: Personality Change, Dyspnoea, Muscular Weakness, Loss of Consciousness, Aggression, Anxiety, Cholelithiasis, Sleep Terror, Abnormal Dreams, Fatigue, Palpitations, Chest Pain, Hypertension
Adverse event resulted in: life threatening event
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Allergy TO Animal
Start date: 2007-02-06
End date: 2007-04-11
Singulair
Administration route: Oral
Start date: 2007-02-06
End date: 2007-04-11
Singulair
Administration route: Oral
Start date: 2007-02-06
End date: 2007-04-11
Other drugs received by patient: Ibuprofen; Vitamins (Unspecified); Calcium (Unspecified)
Adverse event in 56 year old female receiving Singulair (Montelukast)
Reported by a pharmacist from Canada on 2007-06-21
Patient: 56 year old female, weighing 84.0 kg (184.8 pounds)
Adverse reactions / side effects: Personality Change, Dyspnoea, Muscular Weakness, Loss of Consciousness, Aggression, Anxiety, Cholelithiasis, Sleep Terror, Abnormal Dreams, Fatigue, Palpitations, Chest Pain, Hypertension
Adverse event resulted in: life threatening event
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Allergy TO Animal
Start date: 2007-02-06
End date: 2007-04-11
Singulair
Administration route: Oral
Start date: 2007-02-06
End date: 2007-04-11
Singulair
Administration route: Oral
Start date: 2007-02-06
End date: 2007-04-11
Other drugs received by patient: Ibuprofen; Vitamins (Unspecified); Calcium (Unspecified)
Adverse event in 8 year old male receiving Singulair (Montelukast)
Reported by a physician from United States on 2007-05-25
Patient: 8 year old male
Adverse reactions / side effects: Dyspnoea, Swelling Face, Tongue Disorder, Wheezing, Swollen Tongue
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Singulair (Montelukast)
Other drugs received by patient: Zyrtec
Adverse event in female receiving Singulair (Montelukast)
Reported by a pharmacist from United States on 2007-05-24
Patient: female
Adverse reactions / side effects: Dyspnoea, Palpitations, Extrasystoles, Endocrine Disorder, Atrial Fibrillation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Singulair (Montelukast)
Other drugs received by patient: Lasix; Solu-Medrol; Lopressor; Protonix; Morphine; Flovent; Aspirin; Xanax; Tylenol
Adverse event in 8 year old male receiving Singulair (Montelukast)
Reported by a pharmacist from United States on 2007-05-22
Patient: 8 year old male
Adverse reactions / side effects: Dyspnoea, Swelling Face, Tongue Disorder, Wheezing, Swollen Tongue
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Singulair (Montelukast)
Other drugs received by patient: Zyrtec
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-05-15
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Syncope, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-05-11
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 14 year old female receiving Singulair (Montelukast)
Reported by a physician from Slovakia (Slovak Republic) on 2007-03-29
Patient: 14 year old female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Sensation of Foreign Body, Dysphagia, Dyspnoea
Adverse event resulted in: life threatening event
Suspect drug(s):
Singulair (Montelukast)
Other drugs received by patient: Cetirizine Hydrochloride; Allergenic Extract
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-20
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 43 year old female receiving Singulair (Montelukast)
Reported by a physician from United States on 2007-02-19
Patient: 43 year old female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Chest Discomfort, Dyspnoea, Wheezing
Adverse event resulted in: life threatening event
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2006-12-10
End date: 2006-12-10
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2006-12-10
End date: 2006-12-10
Other drugs received by patient: Benadryl; Optivar Ophthalmic Solution; Foradil; Flonase
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-19
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Myalgia, Face Oedema, Fatigue, DRY Mouth, Chest Pain, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-09
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Petechiae, Headache, Somnolence, Generalised Oedema, Myalgia, Fatigue, Chest Pain, DRY Mouth, Abdominal Distension, Dizziness, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Aspirin; Levothyroxine Sodium; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
|
